Results 12,021-12,040 of 32,978 for speaker:Catherine Connolly
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: That is 23 out of the 30.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: What about the remaining seven?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: That was the payment negotiated by Mr. Breen for the State Claims Agency.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: That report is available.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I understand the background to it was the German company had stated, "If the State pays more, we will reduce our contribution". Is that right?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Was that the context in which it was done?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: It was a cut-off date from the German company.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Therefore, the State Claims Agency prepared a report and offered the payment of €62,000, which some accepted.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Did they waive their right to engage in further litigation?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Full and final settlement. Were they children at the time?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Of course, I beg your pardon.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: It would not be counted. We have received correspondence which Mr. Breen has not received and I understand it places him in a particular position. I just want to establish the facts. On the settlements made when some of the people concerned were children, were they ruled on in court?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Was it in full and final settlement? There were no proceedings in train.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Mr. Breen is saying the money was offered and that there was no need to rule on the matter in court, even though they were children. I am just trying to be clear.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: It is Mr. Justice Noonan.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I understand that. However, it was one of the biggest scandals. Had we learned from it, perhaps others might not have happened, but we are where we are. What I am trying to establish is the number of people who have outstanding cases and are receiving nothing from the State. Are there a number who are receiving no payments from the State who have suffered from thalidomide?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: There is the process where they have to be assessed to say they are acknowledged as thalidomide sufferers. If they succeed in that process, they receive what Ms Carr has outlined. At the same time, the unacknowledged cases are taking action in court. Is that correct?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I am almost out of time. The issue of mediation was of concern to the person who wrote to us. It has been said mediation is ongoing, but it was pointed out in the letter that mediation was not ongoing. Mr. Breen has come back with an answer that as neither side has terminated mediation, it is still in being.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I understand and that is Mr. Breen's reply. However, the reality is that no mediation has taken place since 2016. Is that correct? Was that the last mediation?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: To be factual, it has now been corrected. Although Mr. Breen is saying either party could come back as nobody has formally terminated mediation, no mediation has taken place.